Keywords: Forest Labs, Gedeon Richter, cariprazine, schizophrenia, phase III trials

Forest Labs, Gedeon Richter plan 2012 filing for cariprazine

Article | 29 February 2012

Print This

The latest studies examined the drug's role in the treatment of acute exacerbations of schizophrenia,but the drug has also ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in